LncRNA-NEF Suppressed Oxaliplatin Resistance and Epithelial-Mesenchymal Transition in Colorectal Cancer through Epigenetically Inactivating MEK/ERK Signaling

0
145
An oxaliplatin-resistant colorectal cancer cell line was established and lncRNA-Neighboring Enhancer of FOXA2 (NEF) was down-regulated in this resistant cell line.
[Cancer Gene Therapy]
Abstract